Vistagen

Vistagen Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Vistagen, Mental Health Service, 343 Allerton Avenue, South San Francisco, CA.

Vistagen is a late clinical-stage company leveraging its pioneering neuroscience & deep understanding of nose-to-brain neurocircuitry to develop and commercialize a broad and diverse pipeline of intranasal product candidates called pherines (Nasdaq: VTGN)

Tomorrow, March 17th at 9:00 AM ET, Vistagen CEO Shawn Singh will participate in a fireside chat and one-on-one meetings...
03/16/2026

Tomorrow, March 17th at 9:00 AM ET, Vistagen CEO Shawn Singh will participate in a fireside chat and one-on-one meetings at the Stifel 2026 Virtual CNS Forum. Watch the live webcast here: https://bit.ly/4l8ylen

Vistagen today announced that the Company will participate in the Stifel 2026 Virtual CNS Forum on March 17, 2026. For m...
03/03/2026

Vistagen today announced that the Company will participate in the Stifel 2026 Virtual CNS Forum on March 17, 2026. For more details: https://bit.ly/4lppF3H

Vistagen’s President and CEO, Shawn Singh, will present a corporate overview at the 46th Annual TD Cowen Healthcare Conf...
02/25/2026

Vistagen’s President and CEO, Shawn Singh, will present a corporate overview at the 46th Annual TD Cowen Healthcare Conference on Monday, March 2, at 3:50 p.m. ET. For more information: https://bit.ly/3OrvWzr

Vistagen today reported financial results for its fiscal year 2026 third quarter ended December 31, 2025, and provided a...
02/12/2026

Vistagen today reported financial results for its fiscal year 2026 third quarter ended December 31, 2025, and provided a corporate update. The PALISADE-4 Phase 3 trial of fasedienol for acute treatment of Social Anxiety Disorder is proceeding, with topline results from the randomized portion of the trial expected in the first half of 2026. See Vistagen's corporate update here: https://bit.ly/3OEBeY5

Vistagen will host a conference call and webcast today at 2:00 p.m. PT (5:00 p.m. ET) to report results for its fiscal y...
02/12/2026

Vistagen will host a conference call and webcast today at 2:00 p.m. PT (5:00 p.m. ET) to report results for its fiscal year 2026 third quarter ended December 31, 2025, and provide a corporate update. Join here: https://bit.ly/45JDCmj

Vistagen will host a conference call and webcast on Thursday, February 12, 2026, at 2:00 p.m. PT (5:00 p.m. ET) to repor...
02/04/2026

Vistagen will host a conference call and webcast on Thursday, February 12, 2026, at 2:00 p.m. PT (5:00 p.m. ET) to report results for its fiscal year 2026 third quarter ended December 31, 2025, and provide a corporate update. For details: https://bit.ly/3ZOVNDD

Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute T...
12/17/2025

Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder: https://bit.ly/3XVPOw1

12/02/2025

Social anxiety disorder is a profound fear of being watched, judged, or embarrassed, even in everyday situations like school or work. Often beginning in adolescence, it can last for years and show up in different ways depending on life stage, job, or external pressures. Hear our CEO, Shawn Singh, discuss the impacts of social anxiety disorder on the
Inside Biotech podcast.

Vistagen is pleased to announce the appointment of Nick Tressler as Chief Financial Officer, effective today, December 1...
12/01/2025

Vistagen is pleased to announce the appointment of Nick Tressler as Chief Financial Officer, effective today, December 1, 2025. Mr. Tressler brings over 20 years of financial leadership experience in the life sciences industry guiding companies through pivotal growth and transformation. Learn more here: https://bit.ly/4oqxply

Exploratory data presented at The Menopause Society 2025 Annual Meeting demonstrate PH80’s potential as a rapidly-acting...
11/26/2025

Exploratory data presented at The Menopause Society 2025 Annual Meeting demonstrate PH80’s potential as a rapidly-acting pherine product candidate for treating vasomotor symptoms (hot flashes) due to menopause. Research supports the product candidate’s non-hormonal, non-systemic, rapidly-acting effects on autonomic biomarkers. Read more: https://bit.ly/4inpYdG

Vistagen today reported financial results for its fiscal year 2026 second quarter ended September 30, 2025, and provided...
11/13/2025

Vistagen today reported financial results for its fiscal year 2026 second quarter ended September 30, 2025, and provided a corporate update. Read more: https://bit.ly/4p43qRe

Vistagen will host a conference call and webcast today at 2:00 p.m. PT (5:00 p.m. ET) to report results for its fiscal y...
11/13/2025

Vistagen will host a conference call and webcast today at 2:00 p.m. PT (5:00 p.m. ET) to report results for its fiscal year 2026 second quarter ended September 30, 2025, and provide a corporate update. Join here: https://bit.ly/3WPTcrK

Address

343 Allerton Avenue
South San Francisco, CA
94080

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 9am - 5pm
Sunday 9am - 5pm

Telephone

+16505773600

Website

Alerts

Be the first to know and let us send you an email when Vistagen posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Vistagen:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category